Smith Jeffrey T L
- SEC CIK
- 0001604800
In the past year, 2 open-market sale filings worth $475.6K and no purchases.
Current role at each company
- ZYME Zymeworks Inc.EVP & Chief Medical Officeras of Jan 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $475.6K
- 2 filings
- Net
- −$475.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Jeffrey T L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 (view filing) | Jan 12 | Same day | Smith Jeffrey T LEVP & Chief Medical Officer | SSale | −9.31K | $22.67 | −$211.1K | −25.8%26.7K after | |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Smith Jeffrey T LEVP & Chief Medical Officer | SSale | −10.5K | $25.10 | −$264.5K | −36.5%18.4K after | |
| Jan 6, 2025 (view filing) | Jan 6 | Same day | Smith Jeffrey T LEVP & Chief Medical Officer | SSale | −11.1K | $14.92 | −$165.8K | −55.6%8.89K after |